Leukemia Edition: Top Headlines for Week of May 1, 2023

In this edition, immunotherapy improves survival rates of infants with leukemia; extreme poverty linked to higher risk for relapse among children with ALL; FDA approves allogeneic cell therapy and more. Read the full coverage here:

Addition of immunotherapy to chemotherapy improves survival rates of infants with leukemia

Extreme poverty linked to nearly twofold higher risk for relapse among children with ALL

FDA approves allogeneic cell therapy Omisirge for patients with blood cancers

Vaping linked to cancer-related cognitive impairment among young adult cancer survivors

Intervention reduces financial toxicity among people with blood cancers

References:

Healio Interview

Ng DQ, et al. JCO Oncol Pract. 2023;doi:10.1200/op.22.00458.

Press Release

van der Sluis IM, et al. N Eng J Med. 2023;doi:10.1056/NEJMoa2214171.

Wadhwa A, et al. Blood. 2023;doi:10.1182/blood.2023019631.